FR2407208A1 - Nouveaux derives de la n-(tetrazolyl-5)-benzamide et compositions pharmaceutiques les contenant - Google Patents

Nouveaux derives de la n-(tetrazolyl-5)-benzamide et compositions pharmaceutiques les contenant

Info

Publication number
FR2407208A1
FR2407208A1 FR7830625A FR7830625A FR2407208A1 FR 2407208 A1 FR2407208 A1 FR 2407208A1 FR 7830625 A FR7830625 A FR 7830625A FR 7830625 A FR7830625 A FR 7830625A FR 2407208 A1 FR2407208 A1 FR 2407208A1
Authority
FR
France
Prior art keywords
tetrazolyl
new
aryl
pharmaceutical compositions
compositions containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7830625A
Other languages
English (en)
Other versions
FR2407208B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
May and Baker Ltd
Original Assignee
May and Baker Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by May and Baker Ltd filed Critical May and Baker Ltd
Publication of FR2407208A1 publication Critical patent/FR2407208A1/fr
Application granted granted Critical
Publication of FR2407208B1 publication Critical patent/FR2407208B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/32—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing keto groups
    • C07C65/40—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing keto groups containing singly bound oxygen-containing groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/30—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing —CHO groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • C07D257/06—Five-membered rings with nitrogen atoms directly attached to the ring carbon atom

Abstract

L'INVENTION A TRAIT A DE NOUVEAUX DERIVES DE LA N-(TETRAZOLYL-5)-BENZAMIDE. CES DERIVES ONT LA FORMULE CI-DESSOUS DANS LAQUELLE RHALOGENE, ALCOYLE, ALCOXY, ALCOYLTHIO, ALCOYLSULFONYLE, ALCOYLAMINO, ALCOYLSULFAMOYLE, DIALCOYLSULFAMOYLE, DIALCOYLAMINO, DIALCOYLCARBAMOYLE, ALCOXYCARBONYLAMINO, ALCOYLCARBAMOYLE, ALCANOYLAMINO, HYDROXY, NITRO, TRIFLUOROMETHYLE, ARYLE, BENZYLOXYCARBONYLAMINO, AMINO, SULFAMOYLE, TETRAZOLYLE-5, CARBOXY OU CARBAMOYLE, N0, 1 OU 2, RH, ALCOYLE, OU ARYLE, ET RH, ALCOYLE, PHENYLALCOYLE, OU ARYLE SUBSTITUE OU NON. APPLICATION POUR LE TRAITEMENT DES TROUBLES RESPIRATOIRES, NOTAMMENT L'ASTHME BRONCHIQUE ALLERGIQUE. (CF DESSIN DANS BOPI)
FR7830625A 1977-10-28 1978-10-27 Nouveaux derives de la n-(tetrazolyl-5)-benzamide et compositions pharmaceutiques les contenant Granted FR2407208A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB45083/77A GB1588242A (en) 1977-10-28 1977-10-28 N-(tetrazol-5-yl)-salicylamide derivatives

Publications (2)

Publication Number Publication Date
FR2407208A1 true FR2407208A1 (fr) 1979-05-25
FR2407208B1 FR2407208B1 (fr) 1981-12-18

Family

ID=10435819

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7830625A Granted FR2407208A1 (fr) 1977-10-28 1978-10-27 Nouveaux derives de la n-(tetrazolyl-5)-benzamide et compositions pharmaceutiques les contenant

Country Status (5)

Country Link
JP (1) JPS5470275A (fr)
CH (1) CH635328A5 (fr)
DE (1) DE2846891A1 (fr)
FR (1) FR2407208A1 (fr)
GB (1) GB1588242A (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0438869A1 (fr) * 1989-11-30 1991-07-31 Eli Lilly And Company Améliorations relatives des antagonistes de l'angiotensine II
WO2013064459A1 (fr) * 2011-11-03 2013-05-10 Bayer Intellectual Property Gmbh Benzoylamides à substitution éther d'oxime agissant comme herbicides

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4526979A (en) * 1983-07-22 1985-07-02 Merrell Dow Pharmaceuticals Inc. Carbamates and oxalamides of amino-N-(1H-tetrazol-5-yl)benzamides
SE0102764D0 (sv) 2001-08-17 2001-08-17 Astrazeneca Ab Compounds
GB0226930D0 (en) 2002-11-19 2002-12-24 Astrazeneca Ab Chemical compounds
TW200600086A (en) 2004-06-05 2006-01-01 Astrazeneca Ab Chemical compound
WO2006040527A1 (fr) 2004-10-16 2006-04-20 Astrazeneca Ab Procede de fabrication de composes de phenoxy benzamide
TW200714597A (en) 2005-05-27 2007-04-16 Astrazeneca Ab Chemical compounds
NZ575514A (en) 2005-07-09 2009-11-27 Astrazeneca Ab Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes
TW200738621A (en) 2005-11-28 2007-10-16 Astrazeneca Ab Chemical process
TW200825063A (en) 2006-10-23 2008-06-16 Astrazeneca Ab Chemical compounds
SA07280576B1 (ar) 2006-10-26 2011-06-22 استرازينيكا ايه بي مركبات بنزويل أمينو سيكليل غير متجانسة بأعتبارها عوامل منشطة للجلوكوكيناز
BRPI0721143A2 (pt) 2006-12-21 2014-03-11 Astrazeneca Ab Forma cristalina do composto processo para a formação da mesma, uso de um composto, método para tratar doenças mediadas por ativador de glicocinase
EP2324028A2 (fr) 2008-08-04 2011-05-25 AstraZeneca AB Agents thérapeutiques 414
GB0902406D0 (en) 2009-02-13 2009-04-01 Astrazeneca Ab Crystalline polymorphic form
GB0902434D0 (en) 2009-02-13 2009-04-01 Astrazeneca Ab Chemical process
AR076221A1 (es) * 2009-04-09 2011-05-26 Astrazeneca Ab Derivado de pirazol [4,5-e] pirimidina y su uso para tratar diabetes y obesidad
AR076220A1 (es) 2009-04-09 2011-05-26 Astrazeneca Ab Derivados de pirazol [4,5 - e] pirimidina
JP6839174B2 (ja) * 2015-08-25 2021-03-03 バイエル・クロップサイエンス・アクチェンゲゼルシャフト 置換されたケトオキシムベンゾイルアミド類

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2750393A (en) * 1954-12-01 1956-06-12 Sterling Drug Inc Iodinated 5-henzamidotetrazoles and preparation thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2750393A (en) * 1954-12-01 1956-06-12 Sterling Drug Inc Iodinated 5-henzamidotetrazoles and preparation thereof

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0438869A1 (fr) * 1989-11-30 1991-07-31 Eli Lilly And Company Améliorations relatives des antagonistes de l'angiotensine II
WO2013064459A1 (fr) * 2011-11-03 2013-05-10 Bayer Intellectual Property Gmbh Benzoylamides à substitution éther d'oxime agissant comme herbicides
US8957096B2 (en) 2011-11-03 2015-02-17 Bayer Intellectual Property Gmbh Herbicidally active oxime-ether-substituted benzoylamides

Also Published As

Publication number Publication date
GB1588242A (en) 1981-04-23
JPS5470275A (en) 1979-06-05
FR2407208B1 (fr) 1981-12-18
CH635328A5 (en) 1983-03-31
DE2846891A1 (de) 1979-05-10

Similar Documents

Publication Publication Date Title
FR2407208A1 (fr) Nouveaux derives de la n-(tetrazolyl-5)-benzamide et compositions pharmaceutiques les contenant
FR2370041A1 (fr) Nouveaux derives de la n-(tetrazolyl-5-)-benzamide et leurs applications therapeutiques, notamment pour le traitement de troubles respiratoires
DE69621012D1 (de) VERWENDUNG VON NSAIDs ZUR BEHANDLUNG VON PLATTENEPITHELKARZINOM DER MUNDHÖHLE UND KEHLKOPF
ATE205086T1 (de) Verwendung von dem chelatbildner clioquinol zur herstellung eines arzneimittelszur behandlung von alzheimerschen krankheit
DE3684190D1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
FR2411821A1 (fr) Nouveaux 1,9-dihydroxyoctahydrophenanthrenes et 1-hydroxyoctahydrophenanthrene-9-ones et medicament les contenant
FI961809A0 (fi) Uudet (R)-5-karbamoyyli-8-fluori-3-N,N-disubstituoitu-amino 3,4-dihydro-2H-1-bentsopyraanit
BE901667A (fr) Composition analgesique et anti-inflammatoire a base de diphenhydramine, leur preparation et leur utilisation.
MY111260A (en) Pharmaceutical composition for the treatment of nicotine dependence
FR2407207A1 (fr) Nouveaux derives du tetrazole et compositions pharmaceutiques les contenant
FR2453650A1 (fr) Medicament a base de derives du cholecalciferol, utilisable pour regler le metabolisme des os chez les homeothermes
DE68912195D1 (de) Verwendung von Pyrrolicloncarbonsäurealkylestern zur Herstellung eines Arzneimittels zur Behandlung von Ichtyosis.
DE59508961D1 (de) Verwendung von weihrauch zur behandlung der alzheimer-krankheit
ATE309816T1 (de) Topisches arzneimittel mit einem gehalt an ciclosporin
WO1997022354A3 (fr) Emploi d'un medicament et utilisation d'un melange de substances pour la production d'un medicament
DK0615443T3 (da) Lægemiddel i akut virksom form indeholdende Flurbiprofen og anvendelse deraf
ITMI921556A1 (it) Farmaco contenente melatonina e/o agonisti, con somministrazione particolarmente efficace nelle patologie che interferiscono con i ritmi circandiani
FR2754818B1 (fr) Nouveaux derives bi-aromatiques du dibenzofuranne et leur utilisation en medecine humaine ou veterinaire ainsi qu'en cosmetique
ATE216891T1 (de) Verwendung von immunosuppressiva zur behandlung der schizophrenie
TNSN97143A1 (fr) Derives de trans-piperazine-1-yl-spiro(cyclohexane-1, 1'- isobenzofuranne), procede pour leur preparation et compositions pharmaceutiques les contenant
KR880002535A (ko) 약제로서의 15-데옥시스퍼구알린의 용도
FR2658190B1 (fr) Esters d'aminoacides de l'hydroquinone, leur procede de preparation et compositions pharmaceutiques ou cosmetiques les contenant.
ATE131043T1 (de) Arzneimittel enthaltend eine kombination von azt und amantadin für die behandlung von aids.
ATE189385T1 (de) Verwendung von benzonaphtalene-derivaten zur herstellung eines arzneimittels zur behandlung von krankheiten des nervensystems
FR2392674A1 (fr) Compositions pharmaceutiques a base d'elastine

Legal Events

Date Code Title Description
ST Notification of lapse